Mayo aptamer breakthrough for senescent cell tagging in AD/aging
Key Questions
What breakthrough has Mayo Clinic achieved with aptamers for senescent cells?
The aptamer enables reliable detection of senescent 'zombie' cells after decades of prior failures. This directly supports development of senolytic therapies for Alzheimer's and age-related neurodegeneration.
How could the aptamer advance treatments for Alzheimer's and aging?
By tagging senescent cells accurately, the aptamer facilitates targeted removal strategies in Alzheimer's and broader age-related conditions. It addresses a key barrier in senolytic drug development.
What does the student-led research on zombie cells reveal about aging?
Students have identified methods to crack the aging code through improved zombie cell detection. This breakthrough is highlighted as transformative for Alzheimer's, cancer, and Parkinson's research.
Aptamer enables reliable detection of zombie cells after 30 years of failures. Directly supports senolytic development for Alzheimer's and age-related neurodegeneration.